Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.
Saved in:
| Title: | Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis. |
|---|---|
| Authors: | Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Division of Dermatology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA., Pinter A; Department of Dermatology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany., Wine Lee L; Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA., Aschoff R; University Hospital Carl Gustav Carus, Dresden, Germany., Zdybski J; Klinika Zdybski Dermedic, Ostrowiec Świętokrzyski, Poland., Schnopp C; Department of Dermatology and Allergology, Technical University of Munich, Munich, Germany., Khokhar FA; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Praestgaard AH; Sanofi, Cambridge, MA, USA., Bansal A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Shumel B; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Bastian M; Sanofi, Frankfurt, Germany. mike_bastian@gmx.net. |
| Source: | Paediatric drugs [Paediatr Drugs] 2026 May; Vol. 28 (3), pp. 307-320. Date of Electronic Publication: 2026 Apr 02. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Springer International Country of Publication: Switzerland NLM ID: 100883685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2019 (Electronic) Linking ISSN: 11745878 NLM ISO Abbreviation: Paediatr Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41926052 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Paller+AS%22">Paller AS</searchLink>; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Division of Dermatology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Pinter+A%22">Pinter A</searchLink>; Department of Dermatology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Wine+Lee+L%22">Wine Lee L</searchLink>; Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Aschoff+R%22">Aschoff R</searchLink>; University Hospital Carl Gustav Carus, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Zdybski+J%22">Zdybski J</searchLink>; Klinika Zdybski Dermedic, Ostrowiec Świętokrzyski, Poland.<br /><searchLink fieldCode="AU" term="%22Schnopp+C%22">Schnopp C</searchLink>; Department of Dermatology and Allergology, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Khokhar+FA%22">Khokhar FA</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Praestgaard+AH%22">Praestgaard AH</searchLink>; Sanofi, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bansal+A%22">Bansal A</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Shumel+B%22">Shumel B</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bastian+M%22">Bastian M</searchLink>; Sanofi, Frankfurt, Germany. mike&#95;bastian@gmx.net. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100883685%22">Paediatric drugs</searchLink> [Paediatr Drugs] 2026 May; Vol. 28 (3), pp. 307-320. <i>Date of Electronic Publication: </i>2026 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>100883685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2019 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211745878%22">11745878 </searchLink><i>NLM ISO Abbreviation: </i>Paediatr Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41926052 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40272-026-00747-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 307 Titles: – TitleFull: Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Paller AS – PersonEntity: Name: NameFull: Pinter A – PersonEntity: Name: NameFull: Wine Lee L – PersonEntity: Name: NameFull: Aschoff R – PersonEntity: Name: NameFull: Zdybski J – PersonEntity: Name: NameFull: Schnopp C – PersonEntity: Name: NameFull: Khokhar FA – PersonEntity: Name: NameFull: Praestgaard AH – PersonEntity: Name: NameFull: Bansal A – PersonEntity: Name: NameFull: Shumel B – PersonEntity: Name: NameFull: Bastian M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-2019 Numbering: – Type: volume Value: 28 – Type: issue Value: 3 Titles: – TitleFull: Paediatric drugs Type: main |
| ResultId | 1 |